• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • Atacand (candesartan cilexetil)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Interactive area
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Atacand (candesartan cilexetil)

Atacand (candesartan cilexetil) is an angiotensin receptor blocker (ARB), indicated for the treatment of patients with hypertension and patients with chronic heart failure(CHF) and left ventricular systolic dysfunction.

Atacand Plus

Atacand Plus (candesartan cilexetil/hydrochlorothiazide) is a fixed combination of Atacand and the diuretic hydrochlorothiazide (HCTZ), indicated for the treatment of hypertension in patients who need more than monotherapy.

Did you know?

AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.

  • Healthcare professionals
  • Patients and families

Links to country-specific websites can be found using the AstraZeneca websites list.

If you still have a question regarding our drug portfolio you can Contact us.

  • Advanced search

Quick links

  • AstraZeneca US
  • Investor information
  • Press information

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions


AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010